| 货号 | HX959266 |
|---|
| 产品名称 | Research Grade Cizutamig |
|---|
| 中文品名/别名 | Emb 06, Emb06, CN-106, CND-106, CND106 |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | Human |
|---|
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | Tumor necrosis factor receptor superfamily member 17, B-cell maturation protein, CD269, TNFRSF17, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E |
|---|
| 基因号 | Q02223 & P07766 |
|---|
| 宿主/表达体系 | Human |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Cizutamig ( HX959266 ) is a research-grade recombinant antibody targeting CD269 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|